Published in Ann Intern Med on September 01, 1982
Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol (1984) 14.64
The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis (2001) 10.43
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev (1997) 6.98
In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob Agents Chemother (1989) 4.38
Methicillin-resistant staphylococci. Clin Microbiol Rev (1988) 3.77
Comparison of epidemiological markers used in the investigation of an outbreak of methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol (1983) 2.95
Evaluation of mannitol salt agar with oxacillin as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1985) 2.37
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 2.29
An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis (2002) 2.15
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1987) 1.93
Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol (2004) 1.80
Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor. Antimicrob Agents Chemother (2012) 1.52
Clinical implications of positive blood cultures. Clin Microbiol Rev (1989) 1.48
Methicillin-resistant Staphylococcus aureus strains in New York City hospitals: inter-hospital spread of resistant strains of type 88. J Clin Microbiol (1984) 1.47
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47
Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis (2001) 1.43
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies. Antimicrob Agents Chemother (1986) 1.40
A multistrain cluster of methicillin-resistant Staphylococcus aureus based in a native community. Can J Infect Dis (1990) 1.33
Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 1.33
Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev (2014) 1.21
Unusually large number of methicillin-resistant Staphylococcus aureus clones in a Portuguese hospital. J Clin Microbiol (1995) 1.21
Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis (2005) 1.17
DNA fingerprinting of isolates of Staphylococcus aureus from newborns and their contacts. J Clin Microbiol (1991) 1.17
Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis (2008) 1.16
Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.07
Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Nurse Pract (2008) 1.04
Rapid multiplex PCR assay for identification of USA300 community-associated methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol (2006) 1.00
In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 1.00
Screening method for recovery of methicillin-resistant Staphylococcus aureus from primary plates. J Clin Microbiol (1986) 0.98
Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med (1984) 0.94
The emergence of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in Canada. Can J Infect Dis (2003) 0.94
Sporadic "transitional" community-associated methicillin-resistant Staphylococcus aureus strains from health care facilities in the United States. J Clin Microbiol (2007) 0.93
Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia. Can J Infect Dis (2002) 0.89
Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci. Eur J Clin Microbiol Infect Dis (2008) 0.88
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1997) 0.86
Alanine aminopeptidase and beta 2-microglobulin excretion in patients receiving vancomycin and gentamicin. Antimicrob Agents Chemother (1987) 0.84
Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1988) 0.81
Public health surveillance for methicillin-resistant Staphylococcus aureus: comparison of methods for classifying health care- and community-associated infections. Am J Public Health (2010) 0.80
Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia. Emerg Infect Dis (2010) 0.77
Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. Infect Dis Clin North Am (2016) 0.76
Comparison of Methicillin Resistant Staphylococcus Aureus in Healthy Community Hospital Visitors [CA-MRSA] and Hospital Staff [HA-MRSA]. Mediterr J Hematol Infect Dis (2015) 0.75
Prevalence of Staphylococcus aureus, phage type 29/52/80, in Michigan. Am J Public Health (1984) 0.75
Comparison of fluorescence polarization immunoassay and bioassay of vancomycin. J Clin Microbiol (1984) 0.75
The clinical spectrum and antibiotic sensitivity patterns of staphylococcal pyodermas in the community and hospital. Indian J Dermatol (2014) 0.75
Prospective, cross-sectional study on MSSA and MRSA colonisation in hospitalised children. Eur J Pediatr (2015) 0.75
Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med (1982) 3.56
Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease. J Infect Dis (2000) 1.91
Emphysematous gastritis: case report and review. Rev Infect Dis (1990) 1.91
The compromised host and Legionnaires' disease. Ann Intern Med (1979) 1.83
Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med (1992) 1.69
The increasing importance of polymicrobial bacteremia. JAMA (1979) 1.58
Reduction in Legionella pneumophila through heat flushing followed by continuous supplemental chlorination of hospital hot water. J Infect Dis (1990) 1.51
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin. Antimicrob Agents Chemother (1984) 1.39
Listerial prosthetic valve endocarditis. Successful medical therapy. JAMA (1978) 1.24
Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J (1978) 1.15
In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981. Antimicrob Agents Chemother (1983) 1.11
Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy. J Infect Dis (1994) 1.09
Ceforanide: in vitro and clinical evaluation. Antimicrob Agents Chemother (1979) 1.08
The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol (1992) 1.04
Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis (1996) 1.03
Dengue with hemorrhagic manifestations: an imported case from the Middle East. Am J Trop Med Hyg (1984) 1.02
In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones. J Antimicrob Chemother (1988) 1.02
Legionnaires' disease. A cause of lung abscess. JAMA (1979) 0.99
In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. J Antimicrob Chemother (1987) 0.98
Failure of probenecid to alter the pharmacokinetics of ceforanide. Antimicrob Agents Chemother (1981) 0.98
The effect of inoculum, culture medium and antimicrobial combinations on the in-vitro susceptibilities of Legionella pneumophila. J Antimicrob Chemother (1981) 0.98
Antimicrobial susceptibility of Legionella pneumophila Serogroups I--IV. Scand J Infect Dis (1980) 0.96
In vitro susceptibility of Legionella pneumophila, serogroups I-IV. J Infect Dis (1979) 0.96
Failure of therapy in pseudomonas endocarditis: selection of resistant mutants. J Infect Dis (1986) 0.95
A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.92
Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin. J Antimicrob Chemother (1988) 0.89
Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH. J Clin Microbiol (1993) 0.88
Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. AIDS (1995) 0.88
Infected false aneurysms of the femoral artery in intravenous drug addicts. Rev Infect Dis (1989) 0.86
Direct immunofluorescence in the diagnosis of Legionnaires' disease. Chest (1981) 0.86
Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila. Antimicrob Agents Chemother (1980) 0.86
The risk of hepatitis B among select employee groups in an urban hospital. JAMA (1983) 0.84
The in-vitro and in-vivo efficacy of cisplatin and analogues in the treatment of herpes simplex virus-II infections. J Antimicrob Chemother (1987) 0.84
Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control (1985) 0.83
A pseudoepidemic of Legionella infections. Chest (1985) 0.83
In vitro susceptibility of gram-positive cocci to paldimycin. Antimicrob Agents Chemother (1987) 0.82
Nonfatal chromobacterial sepsis. South Med J (1986) 0.80
The potential role of respiratory therapy equipment in cross infection. A study using a canine model for pneumonia. Am Rev Respir Dis (1983) 0.80
The effect of alcohol on HIV infection in vitro. Prog Clin Biol Res (1990) 0.80
Comparison of HIV type 1 RNA plasma viremia, p24 antigenemia, and unintegrated DNA as viral load markers in pediatric patients. AIDS Res Hum Retroviruses (1996) 0.79
Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population. Rev Infect Dis (1987) 0.79
Recurrent pneumococcal bacteremia: 34 episodes in 15 patients. Clin Infect Dis (1998) 0.79
Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS (1997) 0.78
Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia. J Clin Microbiol (1996) 0.78
Activity of quinolones against Legionellaceae. J Antimicrob Chemother (1986) 0.78
Health care worker exposure to HIV-1 and HTLV I-II in critically ill, resuscitated emergency department patients. Ann Emerg Med (1992) 0.78
Comparison of enzyme-multiplied immunoassay technique with fluorescence polarization immunoassay for determination of gentamicin and tobramycin levels in serum. J Clin Microbiol (1984) 0.77
Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients. J Infect Dis (1993) 0.77
Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients. J Acquir Immune Defic Syndr (1994) 0.76
Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. Clin Infect Dis (2001) 0.76
Evaluation of the insulin jet injector as a potential source of infection. Am J Infect Control (1989) 0.76
Aseptic meningitis complicating adult Kawasaki disease: case report and review of the literature. Am J Med (1989) 0.76
An outbreak of gentamicin-resistant Klebsiella pneumoniae: analysis of control measures. Infect Control (1984) 0.76
Treatment of Legionella pneumophila lung abscess with clindamycin. Clin Infect Dis (1995) 0.76
Lack of bacterial aerosols associated with heat and moisture exchangers. Am Rev Respir Dis (1986) 0.75
Structures suggesting cell-wall-deficient forms detected in circulating erythrocytes by fluorochrome staining. Appl Microbiol (1972) 0.75
Comparison of fluorescence polarization immunoassay and bioassay of vancomycin. J Clin Microbiol (1984) 0.75
Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients. Immunol Invest (1995) 0.75
Ophthalmology operating room standards and infection control concerns. Am J Infect Control (1984) 0.75
Isolation guidelines--A or B? Infect Control (1984) 0.75
Serum and crevicular fluid concentrations after a single oral dose of metronidazole. J Periodontol (1986) 0.75
Relative efficacy and toxicity of netilmicin and tobramycin in oncology patients. Arch Intern Med (1986) 0.75
Comparison of intravenous administration with intrauterine irrigation with ceforanide for nonelective cesarean section. Obstet Gynecol (1985) 0.75
Cephapirin therapy in infective endocarditis. South Med J (1983) 0.75
Symposium on infection control. Nurs Clin North Am (1980) 0.75
Role of surveillance in the epidemiology of nosocomial infections: overview of measurements in a surveillance program. Infect Control Urol Care (1982) 0.75
Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy. AIDS Res Hum Retroviruses (1993) 0.75
The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit. Henry Ford Hosp Med J (1992) 0.75
Legionella pneumophila serotype 3. A newly recognized pathogen. Arch Intern Med (1980) 0.75
Filtration of dialysate using an on-line dialysate filter. Int J Artif Organs (1991) 0.75
Susceptibility of Legionella pneumophila to AZT. J Antimicrob Chemother (1988) 0.75
Infection surveillance in cardiac transplantation. Am J Infect Control (1988) 0.75
The effect of heat upon the interaction between aminoglycosides and semi-synthetic penicillins in human serum: a consideration for HIV infectious serum. Scand J Infect Dis (1987) 0.75